Doctor profile · Federal record
Dr. MOHAMMAD RIAZ, MD
Medical Oncology Physician (CMS: MEDICAL ONCOLOGY) · Hematology (Internal Medicine) Physician · KATY, TX
- NPI 1619947421
- Accepts Medicare
- MIPS 99.1 / 100 · 2023
- 37 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
410 W GRAND PKWY S STE 4C
KATY, TX 774948361
(281) 647-7766
fax (281) 647-7767 - Additional location
-
9230 Katy Fwy Ste 410
Houston, TX 770557468
(281) 556-6622
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- September 5, 2025
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #K1023
- Medicaid
- TX #137382113
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619947421. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,252
Distinct HCPCS
10
Medicare allowed
$266,083
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 5,820 | 40 | $21 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,510 | 13 | $1 | |
J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) | 488 | 27 | $1 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 363 | 24 | $28 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 287 | 101 | $128 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 256 | 24 | $29 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 236 | 24 | $131 | |
96417 |
Administration of additional new drug or substance into vein, 1 hour or less | 234 | 23 | $65 | |
96361 |
Infusion into a vein for hydration, each additional hour | 232 | 26 | $13 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 203 | 20 | $1 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 603. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$159
Transactions
6
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| TAIHO ONCOLOGY, INC. | 2 | $58.04 | |
| Celgene Corporation | 2 | $52.30 | |
| Daiichi Sankyo Inc. | 1 | $24.87 | |
| Janssen Biotech, Inc. | 1 | $23.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
245
Patients
46
Total drug cost
$768,074
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 44 | 26 | $652 |
| Prochlorperazine Maleate | Generic | 33 | 20 | $536 |
| Gabapentin | Generic | 18 | 0 | $231 |
| Venclexta (Venetoclax) | Brand | 18 | 0 | $205,648 |
| Eliquis (Apixaban) | Brand | 17 | 0 | $11,884 |
| Tagrisso (Osimertinib Mesylate) | Brand | 17 | 0 | $297,243 |
| Warfarin Sodium | Generic | 17 | 0 | $41 |
| Hydroxyurea | Generic | 16 | 0 | $437 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 15 | 0 | $297 |
| Imbruvica (Ibrutinib) | Brand | 15 | 0 | $250,403 |